Skip to main content
Macrogen, Inc. logo

Macrogen, Inc. — Investor Relations & Filings

Ticker · 038290 ISIN · KR7038290003 KO Professional, scientific and technical activities
Open in API
Filings indexed 352 across all filing types
Latest filing 2022-03-25 Director's Dealing
Country KR South Korea
Listing KO 038290

About Macrogen, Inc.

https://www.macrogen.com/en/main

Macrogen, Inc. is a biotechnology company specializing in precision medicine and genomic analysis. It provides a comprehensive suite of services, including Next-Generation Sequencing (NGS), Sanger sequencing, and spatial transcriptome analysis, to a global client base. The company's core activities are focused on three key areas: Research and Data Analysis, offering fast and accurate genomic services to the scientific community; Clinical Diagnostics, advancing disease prediction through the integration of genomic and medical big data; and Personal Healthcare, providing genetic tests for wellness, nutrition, and disease risk assessment. By combining its extensive genomic expertise with big data and AI, Macrogen aims to deliver hyper-personalized healthcare solutions and innovate in the field of future medicine.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an individual (Cho Eunjeong) regarding their holdings in Macrogen. This type of filing is a standard regulatory requirement for insider trading/shareholding disclosures, which corresponds to the 'Director's Dealing' category.
2022-03-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as a 'Section 16' equivalent in the US) used to disclose insider trading or changes in share ownership by company directors and executives. Based on the provided definitions, this falls under 'Director's Dealing'.
2022-03-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Kwon Nak-jung) of Macrogen. This type of filing is a standard regulatory requirement for reporting insider transactions (purchases/sales of company shares by directors or executives). According to the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2022-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It provides a summary of the audit opinion (which is 'unqualified' or '적정'), key financial data (assets, liabilities, equity, revenue, profit), and details regarding the external auditor. While it contains financial data, it is a standard regulatory disclosure announcement regarding the completion and submission of the audit report, rather than the full annual report (10-K) itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2021
2022-03-23 Korean
사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for Macrogen Inc. for the fiscal year ending December 31, 2021. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. This is a comprehensive financial report for a full fiscal year, which fits the definition of an Annual Report (10-K) in the provided schema, as it contains the full audited financial performance and activity for the year. FY 2021
2022-03-23 Korean
[기재정정]사업보고서 (2021.12)
Annual Report Classification · 95% confidence The document is a 'Business Report' (사업보고서) from Macrogen, which is a comprehensive annual filing in the Korean regulatory system. It contains detailed sections on market conditions, business segments, products, services, and financial outlook. While it is a 'correction' (정정) filing, it constitutes the full annual business report itself, which aligns with the definition of an Annual Report (10-K) in the provided schema. FY 2021
2022-03-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.